Literature DB >> 34062154

Paradoxical functions of long noncoding RNAs in modulating STAT3 signaling pathway in hepatocellular carcinoma.

Chakrabhavi Dhananjaya Mohan1, Shobith Rangappa2, S Chandra Nayak3, Gautam Sethi4, Kanchugarakoppal S Rangappa5.   

Abstract

Hepatocellular carcinoma (HCC) is one of the lethal and leading types of cancer threatening the globe with a high mortality rate. STAT3 is an oncogenic transcription factor that is aberrantly activated in several human malignancies including HCC. Many STAT3-driven genes control cell proliferation and survival, apoptotic resistance, cell cycle progression, metastasis, and chemotherapeutic resistance. STAT3 signaling is regulated by endogenous modulators such as protein tyrosine phosphatase (PTP), suppressor of cytokine signaling (SOCS), protein inhibitor of activated STAT (PIAS), and various long noncoding RNAs (lncRNAs). Interestingly, lncRNAs have been reported to exhibit oncogenic and tumor suppressor functions, and these effects are mediated through diverse molecular mechanisms including sponging of microRNAs (miRs), transcription activation/inhibition, and epigenetic modifications. In this article, we have discussed the possible role of STAT3 signaling in hepatocarcinogenesis and various mechanisms by which lncRNAs impart their oncogenic or tumor suppressive action by modulating the STAT3 pathway in HCC.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HCC; Molecular sponging; Noncoding RNAs; Oncogenic; STAT3; Tumor suppressor; ceRNA

Year:  2021        PMID: 34062154     DOI: 10.1016/j.bbcan.2021.188574

Source DB:  PubMed          Journal:  Biochim Biophys Acta Rev Cancer        ISSN: 0304-419X            Impact factor:   10.680


  7 in total

Review 1.  Emerging role of exosomes in cancer progression and tumor microenvironment remodeling.

Authors:  Mahshid Deldar Abad Paskeh; Maliheh Entezari; Sepideh Mirzaei; Amirhossein Zabolian; Hossein Saleki; Mohamad Javad Naghdi; Sina Sabet; Mohammad Amin Khoshbakht; Mehrdad Hashemi; Kiavash Hushmandi; Gautam Sethi; Ali Zarrabi; Alan Prem Kumar; Shing Cheng Tan; Marios Papadakis; Athanasios Alexiou; Md Asiful Islam; Ebrahim Mostafavi; Milad Ashrafizadeh
Journal:  J Hematol Oncol       Date:  2022-06-28       Impact factor: 23.168

2.  Omega-3 Polyunsaturated Fatty Acids Provoke Apoptosis in Hepatocellular Carcinoma through Knocking Down the STAT3 Activated Signaling Pathway: In Vivo and In Vitro Study.

Authors:  Noura M Darwish; Mohamed M A Elshaer; Saeedah Musaed Almutairi; Tse-Wei Chen; Mohamed Othman Mohamed; Wael B A Ghaly; Rabab Ahmed Rasheed
Journal:  Molecules       Date:  2022-05-09       Impact factor: 4.927

3.  Long Non-Coding RNA LINC01572 Promotes Hepatocellular Carcinoma Progression via Sponging miR-195-5p to Enhance PFKFB4-Mediated Glycolysis and PI3K/AKT Activation.

Authors:  Shihui Lai; Zhipeng Quan; Yuesong Hao; Jun Liu; Zhiqian Wang; Luo Dai; Hongliang Dai; Songqing He; Bo Tang
Journal:  Front Cell Dev Biol       Date:  2021-12-14

Review 4.  The role of ceRNA-mediated diagnosis and therapy in hepatocellular carcinoma.

Authors:  Yi Shi; Ji-Bin Liu; Jing Deng; Da-Zhi Zou; Jian-Jun Wu; Ya-Hong Cao; Jie Yin; Yu-Shui Ma; Fu Da; Wen Li
Journal:  Hereditas       Date:  2021-11-10       Impact factor: 3.271

Review 5.  Flavonoids Inhibit Cancer by Regulating the Competing Endogenous RNA Network.

Authors:  Chengshun Li; Xiaolan Li; Ziping Jiang; Dongxu Wang; Liqun Sun; Jiaqi Li; Yang Han
Journal:  Front Oncol       Date:  2022-03-18       Impact factor: 6.244

6.  2,3,5,6-Tetramethylpyrazine Targets Epithelial-Mesenchymal Transition by Abrogating Manganese Superoxide Dismutase Expression and TGFβ-Driven Signaling Cascades in Colon Cancer Cells.

Authors:  Young Yun Jung; Chakrabhavi Dhananjaya Mohan; Huiyan Eng; Acharan S Narula; Ojas A Namjoshi; Bruce E Blough; Kanchugarakoppal S Rangappa; Gautam Sethi; Alan Prem Kumar; Kwang Seok Ahn
Journal:  Biomolecules       Date:  2022-06-25

7.  3-Formylchromone Counteracts STAT3 Signaling Pathway by Elevating SHP-2 Expression in Hepatocellular Carcinoma.

Authors:  Chakrabhavi Dhananjaya Mohan; Min Hee Yang; Shobith Rangappa; Arunachalam Chinnathambi; Sulaiman Ali Alharbi; Tahani Awad Alahmadi; Amudha Deivasigamani; Kam Man Hui; Gautam Sethi; Kanchugarakoppal S Rangappa; Kwang Seok Ahn
Journal:  Biology (Basel)       Date:  2021-12-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.